Advertisement
Screener

Portola Pharmaceuticals, Inc. Form D

Portola Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2009-06-15: Federal exemption Rule 506; Types of securities offered Equity; Offering of Series C Preferred Stock and the underlying shares of Common Stock issuable upon conversion of the Series C Preferred Stock; Date of first sale 2008-07-09; Total offering amount $60,099,999.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2009-06-15
D/A
Rule 506Equity; Offering of Series C Preferred Stock and the underlying shares of Common Stock issuable upon conversion of the Series C Preferred Stock2008-07-09$60,099,999$60,099,999$055